Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Today's pre-market stock movers: TWTR, QCOM, BAC, BK and more

avatar
Moomoo Breakfast US wrote a column · Apr 18, 2022 20:16
Gainers:
$Natus Medical (NTUS.US)$ +28.6% (to be acquired by ArchiMed Group for $33.50/share in cash)
$Middlefield Banc (MBCN.US)$ +6.1% (Ancora Issues Open Letter to Middlefield Banc Corp. Shareholders)
$Sinclair Broadcast Group (SBGI.US)$ +5% (Sinclair Broadcast and Charter Communications (CHTR.) reach a comprehensive distribution agreement)
$Castle Biosciences (CSTL.US)$ +4.1% (announces a recent poster presentation highlighting data and concluding that its non-invasive skin scraping technique produces sufficient ribonucleic acid to assess reproducible gene expression for its inflammatory skin disease pipeline test)
$Twitter (Delisted) (TWTR.US)$ +3.9% (adopts limited duration shareholder rights plan, enabling all shareholders to realize full value of company; also Thoma Bravo mulling bid for Twitter)
$Ocugen (OCGN.US)$ +3.3% (to commercialize COVAXIN in Mexico, rights now encompassing all of North America)
$Black Diamond Therapeutics (BDTX.US)$ +2.9% (doses first patient in Phase 1 Study of BDTX-1535)
$East Stone Acquisition Corp (ESSC.US)$ +2.5% (announces business combination with ICONIQ Holding)
$Bank of New York Mellon (BK.US)$ +2.14% (earnings report)
$Synchrony Financial (SYF.US)$ +2.1% (earnings report)
$Bank of America (BAC.US)$ +1.2% (earnings report)
$Microvast (MVST.US)$ +1.1% (Statement on Status Under Holding Foreign Companies Accountable Act)
Analyst comments:
$Gap Inc (GPS.US)$ +1.9% (upgraded to Equal-Weight from Underweight at Morgan Stanley)
$Biogen (BIIB.US)$ +1.7% (upgraded to Overweight from Equal Weight at Wells Fargo)
$Comerica (CMA.US)$ +0.9% (upgraded to Neutral from Underperform at Robert Baird)
Losers:
$TG Therapeutics (TGTX.US)$ -31.86% (voluntarily withdraws BLA/sNDA for U2 to treat patients with CLL and SLL)
$Nektar Therapeutics (NKTR.US)$ -23.21% (Nektar Therapeutics and Bristol Myers Squibb decide to end clinical development program for bempegaldesleukin in combination with Opdivo)
$Avadel Pharmaceuticals (AVDL.US)$ -4.7% (filed a complaint against Jazz Pharmaceuticals)
Analyst comments:
$Red Robin (RRGB.US)$ -2.2% (downgraded to Mkt Perform from Outperform at Raymond James)
$Aptiv PLC (APTV.US)$ -2.1% (downgraded to Underweight from Neutral at Piper Sandler)
$Sirius XM (SIRI.US)$ -1.9% (downgraded to Underweight from Equal-Weight at Morgan Stanley)
$SLM Corp (SLM.US)$ -1.4% (downgraded to Equal-Weight from Overweight at Stephens)
$United Airlines (UAL.US)$ -1.4% (downgraded to Neutral from Buy at UBS)
$Qualcomm (QCOM.US)$ -1.3% (downgraded to Neutral from Outperform at SMBC Nikko)
Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only. Read more
14
3
1
+0
Translate
Report
372K Views
Comment
Sign in to post a comment